These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35395704)

  • 1. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance.
    Yang J; Jia Z; Zhang J; Pan X; Wei Y; Ma S; Yang N; Liu Z; Shen Q
    Adv Healthc Mater; 2022 Jul; 11(13):e2102799. PubMed ID: 35395704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
    Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
    ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
    Mokhtarpour K; Razi S; Rezaei N
    Breast Cancer Res Treat; 2024 Oct; 207(3):497-513. PubMed ID: 38874688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
    Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
    Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
    Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
    J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
    Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
    Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231.
    Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer.
    Takatani-Nakase T; Ikushima C; Sakitani M; Nakase I
    Life Sci; 2024 Feb; 339():122411. PubMed ID: 38184272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin induces autophagy-dependent ferroptosis in MDA-MB-231 cells via the mevalonate pathway.
    Tang WJ; Xu D; Liang MX; Wo GQ; Chen WQ; Tang JH; Zhang W
    Heliyon; 2024 Mar; 10(5):e27084. PubMed ID: 38444467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Au-Fe
    Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
    J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Intervention of NF2-YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC.
    Hou L; Pu L; Chen Y; Bai Y; Zhou Y; Chen M; Wang S; Lv Y; Ma C; Cheng P; Zhang K; Liang Q; Deng S; Wang D
    ACS Nano; 2022 Apr; 16(4):5807-5819. PubMed ID: 35420780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
    Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
    Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer.
    Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y
    ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
    Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
    Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
    Wang Y; Sun Y; Wang F; Wang H; Hu J
    Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
    Lee J; Roh JL
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.